Listing Page

Tag: Market Intelligence

Reshoring Early-Stage Pharma
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
Can the U.S. Stop Buying Drugs from China?
The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...
Read More >
A Look at Reshoring Drug Manufacturing: A Q&A With LGM Pharma’s Hamilton Lenox
When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains...
Read More >
Risk Management Practices to Address Pharmaceutical Sourcing Challenges
It may seem odd to be discussing sourcing challenges considering the overwhelming evidence we now have...
Read More >
Increasing Demand for Cold Chain Logistics
Last month, in a post on supply chain risks, we referenced the growing cold chain logistics trend...
Read More >
Confronting Drug Supply Chain Risks
The current coronavirus epidemic and subsequent shutdown of travel to and from affected areas in China...
Read More >